NSE filing, NSE: WALPAR. Summary written from the filing by ALFA Finder's alert engine.
Walpar Nutritions Ltd: key numbers
- Share price
- ₹25.00
- Market cap
- ₹23.48 Cr
- Revenue (annual)
- ₹78.79 Cr
- Net profit (annual)
- ₹3.00 Cr
- P/E (TTM)
- 7.8×Sector 46.1×
- Promoter holding
- 68.99%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Walpar Nutritions Ltd
All →Walpar Nutritions Other Announcement
Walpar Nutritions filed a non-applicability intimation for corporate governance provisions under LODR, citing its SME listing. No transaction or business decision is involved.
Walpar Nutritions Annual General Meeting
Walpar Nutritions held its 6th AGM on 23 Sep 2026, approving routine resolutions on auditor re-appointment, director rotations, and related party transactions.
Walpar Nutritions Annual General Meeting
Walpar Nutritions Limited issued a notice for its Annual General Meeting to be held on August 23, 2026. The meeting agenda includes financial statement adoption and RPT approvals.
Walpar Nutritions Management Change
Walpar Nutritions Limited announced the re-appointment of four Independent Directors and its Statutory Auditor for fresh 60-month terms.
Walpar Nutritions Board Meeting Outcome
Walpar Nutritions Limited's board appointed statutory auditors for five years, re-appointed four independent directors, and approved holding the 6th AGM on September 23, 2026.
Walpar Nutritions Results Correction
Walpar Nutritions rectified a typographical error in its FY2025 XBRL filing regarding Consolidated Total Tax. The company confirmed no other changes to previously submitted financial information.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.